Cysteinyl‐leukotrienes and their receptors in asthma and other inflammatory diseases: Critical update and emerging trends
- 7 August 2006
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 27 (4), 469-527
- https://doi.org/10.1002/med.20071
Abstract
Cysteinyl‐leukotrienes (cysteinyl‐LTs), that is, LTC4, LTD4, and LTE4, trigger contractile and inflammatory responses through the specific interaction with G protein‐coupled receptors (GPCRs) belonging to the purine receptor cluster of the rhodopsin family, and identified as CysLT receptors (CysLTRs). Cysteinyl‐LTs have a clear role in pathophysiological conditions such as asthma and allergic rhinitis (AR), and have been implicated in other inflammatory conditions including cardiovascular diseases, cancer, atopic dermatitis, and urticaria. Molecular cloning of human CysLT1R and CysLT2R subtypes has confirmed most of the previous pharmacological characterization and identified distinct expression patterns only partially overlapping. Interestingly, recent data provide evidence for the immunomodulation of CysLTR expression, the existence of additional receptor subtypes, and of an intracellular pool of CysLTRs that may have roles different from those of plasma membrane receptors. Furthermore, genetic variants have been identified for the CysLTRs that may interact to confer risk for atopy. Finally, a crosstalk between the cysteinyl‐LT and the purine systems is being delineated. This review will summarize and attempt to integrate recent data derived from studies on the molecular pharmacology and pharmacogenetics of CysLTRs, and will consider the therapeutic opportunities arising from the new roles suggested for cysteinyl‐LTs and their receptors. © 2006 Wiley Periodicals, Inc. Med Res Rev, 27, No. 4, 469–527, 2007Keywords
This publication has 435 references indexed in Scilit:
- Expression of 5‐lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin‐intolerant asthmaThe Journal of Pathology, 2006
- Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trialJournal of the American Academy of Dermatology, 2005
- Expression of cysteinyl leukotriene receptor 1 in human traumatic brain injury and brain tumorsNeuroscience Letters, 2004
- A cysteinyl leukotriene 2 receptor variant is associated with atopy in the population of Tristan da CunhaPharmacogenetics, 2003
- Functional Characterization of Cysteinyl Leukotriene CysLT2 Receptor on Human Coronary Artery Smooth Muscle CellsBiochemical and Biophysical Research Communications, 2001
- The Molecular Characterization and Tissue Distribution of the Human Cysteinyl Leukotriene CysLT2 ReceptorBiochemical and Biophysical Research Communications, 2000
- Adhesion promotes transcellular leukotriene biosynthesis during neutrophil-glomerular endothelial cell interactions: Inhibition by antibodies against CD18 and L-selectinBiochemical and Biophysical Research Communications, 1992
- Leukotriene A4 hydrolase activity of human airway epithelial cellsBiochemical and Biophysical Research Communications, 1989
- Binding of leukotrienes C4 and D4 to membranes from guinea pig lung: Regulation by ions and gaunine nucleotidesLife Sciences, 1983
- Evidence for multiple leukotriene D4 receptors in smooth muscleLife Sciences, 1982